ZARGUS 2 MG COM REV CT BL AL PLAS TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1057305990054 -
GGREM
552920020110417 -
Código de barras
7896181922254
O que a fonte publica
- Detentor do registro
- ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A
- Princípios ativos
- RISPERIDONA
- Embalagem
- 2 MG COM REV CT BL AL PLAS TRANS X 30
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Similar
- Classe terapêutica
- N5A1 - ANTIPSICÓTICOS ATÍPICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "ZARGUS 2 MG COM REV CT BL AL PLAS TRANS X 30",
"holder": "ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7896181922254"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "552920020110417",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.659.463/0029-92",
"priceRegime": "Regulado",
"productName": "ZARGUS",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "2 MG COM REV CT BL AL PLAS TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "196.73",
"icms-12": "223.56",
"icms-17": "237.02",
"icms-18": "239.91",
"icms-19": "242.88",
"icms-20": "245.91",
"icms-21": "249.03",
"icms-22": "252.22",
"icms-23": "255.49",
"icms-17.5": "238.46",
"icms-19.5": "244.39",
"icms-20.5": "247.46",
"icms-22.5": "253.85",
"icms-12-alc": "220.87",
"icms-17-alc": "234.18",
"icms-18-alc": "237.04",
"icms-19-alc": "239.96",
"icms-20-alc": "242.96",
"icms-21-alc": "246.04",
"icms-22-alc": "249.19",
"icms-23-alc": "252.43",
"withoutTaxes": "194.37",
"icms-17.5-alc": "235.60",
"icms-19.5-alc": "241.45",
"icms-20.5-alc": "244.49",
"icms-22.5-alc": "250.80"
},
"pisCofinsList": "Positiva",
"substanceText": "RISPERIDONA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "271.17",
"icms-12": "308.15",
"icms-17": "326.71",
"icms-18": "330.69",
"icms-19": "334.78",
"icms-20": "338.96",
"icms-21": "343.26",
"icms-22": "347.66",
"icms-23": "352.17",
"icms-17.5": "328.69",
"icms-19.5": "336.87",
"icms-20.5": "341.10",
"icms-22.5": "349.91",
"icms-12-alc": "305.34",
"icms-17-alc": "323.74",
"icms-18-alc": "327.69",
"icms-19-alc": "331.73",
"icms-20-alc": "335.88",
"icms-21-alc": "340.14",
"icms-22-alc": "344.49",
"icms-23-alc": "348.97",
"withoutTaxes": "268.70",
"icms-17.5-alc": "325.70",
"icms-19.5-alc": "333.79",
"icms-20.5-alc": "337.99",
"icms-22.5-alc": "346.72"
},
"invalidBarcodes": [],
"activeSubstances": [
"RISPERIDONA"
],
"therapeuticClass": "N5A1 - ANTIPSICÓTICOS ATÍPICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1057305990054",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N5A1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:552920020110417"